Cureus
Glucagon-Like Peptide-1 (GLP-1)-Based Therapies and Heart Failure Outcomes: A Scoping Review of Contemporary Randomized Controlled Trials
Systematic review of randomised trialsInterventions
The paper
New York Institute of Technology
Cureus, 7 Jul 2026
